
Loading, please wait...

Loading, please wait...

Incidental pulmonary embolism (iPE) is frequently encountered in clinical practice, appearing in approximately 1% of non-dedicated thoracic CT examinations. Managing these findings is often difficult because initial reports may lack diagnostic certainty. Consequently, clinicians frequently order dedicated CT pulmonary angiography (CTPA) to confirm the presence of a clot. However, recent research suggests that a formal expert review might be a more efficient alternative for incidental pulmonary embolism diagnosis.
In a retrospective study of over 25,000 CT scans, only 48% of patients who underwent follow-up CTPA actually had a confirmed pulmonary embolism. This discrepancy highlights a high rate of false-positive reports in non-dedicated studies. Furthermore, the study demonstrated that retrospective expert review by subspecialist radiologists showed excellent agreement with CTPA results (Kappa = 0.94). Therefore, utilizing expert consultation can significantly improve the accuracy of an incidental pulmonary embolism diagnosis. This approach potentially prevents up to 43% of unnecessary follow-up imaging. Consequently, this strategy reduces patient radiation exposure and healthcare costs.
For clinicians in India, where resource optimization is vital, these findings advocate for a multidisciplinary approach. Instead of immediately proceeding to CTPA, hospitals should consider implementing an internal review process. Specifically, when the initial diagnostic certainty is low, a second opinion from a senior radiologist can clarify the situation. This strategy ensures that only patients with a high likelihood of true PE receive further invasive or contrast-heavy investigations. Moreover, this refinement in workflow enhances overall patient safety.
Research indicates that incidental PE is found in approximately 1% of all contrast-enhanced thoracic CT scans not specifically designed for PE protocols.
Yes, expert review has shown a 94% agreement rate with CTPA findings. It can effectively confirm or exclude a diagnosis, potentially reducing unnecessary follow-up scans by 43%.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study shows expert review of incidental PE on non-dedicated CTs matches CTPA accuracy and can reduce unnecessary follow-up imaging by 43%....
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today